cystic fibrosis

The multiplexed PCR kit will target mutations associated with cystic fibrosis that are highly prevalent in the US, and the firm is also eyeing the Middle East and Africa.

Agena's cystic fibrosis panel includes more than 70 mutations in the CFTR gene that have been linked to the disease.

The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.